A spinoff company, Athira Pharma (formalized as M3 Biotechnology before rebranding), was founded in 2011 by PhD student Leen Kawas to commercialize dihexa and a related molecule, ATH-1017 (fosgonimeton)
Just one tiny scoop a day to help support lean mass, strength, and real energy, especially when you're pushing through strength training on limited fuel
Many patients report benefits, and the mechanisms are well supported
The hypothesis has expanded to include vascular dysfunction, oxidative stress, microglial activation, and impaired proteolysis (Roda et al., 2022)
With brand-name GLP-1s costing over $1,000 a month, lots of people have turned to compounded versions (the ones made by compounding pharmacies, often much cheaper)
U.S.-licensed clinicians on every prescription, no auto-approvals